the Focus of the Study is to Correlate the Growth Factors in Serum With the Progenitor Cells in LiverNCT01312220
Growth Factors and Hepatic Progenitor Cells in Acute Liver Failure
An observational study of the Focus of the Study is to Correlate the Growth Factors in Serum With the Progenitor Cells in Liver, run by National Taiwan University Hospital at 1 site in Taiwan.
Trial summary
To study the correlation of serological growth factors and the hepatic progenitor cells involved in liver regeneration of liver failure. Read more about this study
- Who is it for?
- Ages 18 to 75 years
- Conditions the study is for
- the Focus of the Study is to Correlate the Growth Factors in Serum With the Progenitor Cells in Liver
- How many people
- 10 participants
- Where
- 1 siteTaiwan
- Study dates
- Feb 2011to Feb 2013
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: acute liver failure who received liver transplantation
Who may be able to join
- Acute liver failure Received iver transplantation
Who cannot join
- Pregnancy Sepsis Heart failure
Trial locations and contacts
1 site in 1 country.
Taiwan1 site, 1 recruiting
- Recruiting
NTUH
Taipei, Taiwan, 100
CM Ho, MD, +88623123456 ext. 65914, miningho@ntu.edu.tw
About this study
Official title: Relationship of Serological Growth Factors and Hepatic Progenitor Cells in Acute Liver Failure
To study the correlation of serological growth factors and the hepatic progenitor cells involved in liver regeneration of liver failure.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Mar 2011 (estimated)
- Study startFeb 2011
- Study completionFeb 2013 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for the Focus of the Study is to Correlate the Growth Factors in Serum With the Progenitor Cells in LiverStudies of the same condition, open and under way.
- More trials run by National Taiwan University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Enrolment
- 10 participants (estimated)
Sponsor and investigators
- Lead sponsor
- National Taiwan University Hospital
- Sponsor type
- University, hospital or other
- Investigators
- CM Ho, MD, Principal investigator, National Taiwan University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01312220
- Sponsor's protocol ID
- 201101061RC
- Status last verified
- Feb 2011
- First submitted
- 8 Mar 2011
- Last updated
- 10 Mar 2011
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 10 Mar 2011. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Relationship of Serological Growth Factors and Hepatic Progenitor Cells in Acute Liver Failure
- ClinicalTrials.gov ID
- NCT01312220
- Acronym / sponsor ID
- 201101061RC
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 10 participants (estimated)
- Lead sponsor
- National Taiwan University HospitalUniversity, hospital or other
- Study start
- Feb 2011
- Study completion
- Feb 2013 (estimated)
- First posted
- 10 Mar 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To study the correlation of serological growth factors and the hepatic progenitor cells involved in liver regeneration of liver failure.
Study design
- Observational model
- Cohort
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- acute liver failure who received liver transplantation
Key inclusion criteria (1 listed)
- Acute liver failure Received iver transplantation
Key exclusion criteria (1 listed)
- Pregnancy Sepsis Heart failure
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Mar 2011.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
CM Ho, MD principal investigator
National Taiwan University Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of the Focus of the Study is to Correlate the Growth Factors in Serum With the Progenitor Cells in Liver, run by National Taiwan University Hospital at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 10 Mar 2011. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact CM Ho, MD (+88623123456 ext. 65914, miningho@ntu.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Mar 2011.